Vext Science, Inc.
VEXT
CNSX
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 8.10M | 9.19M | 9.11M | 8.18M | 7.67M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.10M | 9.19M | 9.11M | 8.18M | 7.67M |
| Cost of Revenue | 5.29M | 6.52M | 4.41M | 3.84M | 2.80M |
| Gross Profit | 2.80M | 2.67M | 4.70M | 4.34M | 4.88M |
| SG&A Expenses | 2.70M | 900.60K | 2.80M | 2.08M | 2.69M |
| Depreciation & Amortization | 1.83M | 1.09M | 1.09M | 1.32M | 894.70K |
| Other Operating Expenses | -6.00K | -6.00K | -6.00K | 0.00 | -- |
| Total Operating Expenses | 9.82M | 8.50M | 8.29M | 7.24M | 6.38M |
| Operating Income | -1.72M | 683.20K | 819.90K | 939.90K | 1.29M |
| Income Before Tax | -2.90M | -605.60K | -1.07M | 80.80K | 614.00K |
| Income Tax Expenses | -1.06M | -1.14M | -1.14M | -6.21M | 190.40K |
| Earnings from Continuing Operations | -1.84M | 535.50K | 73.10K | 6.29M | 423.50K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.84M | 535.50K | 73.10K | 6.29M | 423.50K |
| EBIT | -1.72M | 683.20K | 819.90K | 939.90K | 1.29M |
| EBITDA | 584.30K | 2.49M | 2.62M | 2.67M | 2.87M |
| EPS Basic | -0.01 | 0.00 | 0.00 | 0.04 | 0.00 |
| Normalized Basic EPS | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | 0.00 | 0.00 | 0.04 | 0.00 |
| Normalized Diluted EPS | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 149.77M | 149.73M | 149.51M | 140.91M | 138.27M |
| Average Diluted Shares Outstanding | 150.08M | 150.10M | 149.74M | 140.91M | 140.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
